Sign in
Active, not recruitingNo phase

Kaneka Endovascular Embolization and Protection

Key facts

Who runs it
Kaneka Medical America LLC
Where
Cleveland, Grand Blanc, New York, and Oklahoma City, United StatesSee the 4 sites
Trial code
Status
Active, not recruiting
People taking part
164 people, planned
Started
13 Dec 2022
Ended
Dec 2025
Type of study
Interventional
Treatments tested
  • i-ED COIL
Record updated
7 October 2025

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • Target aneurysm of 4mm - 14mm in size
  • Ruptured or unruptured
  • Suitable for embolization with coils
  • May be treated with or without assist devices

Who cannot take part

  • Unstable neurological deficit in unruptured cases (condition worsening within last 90 days)
  • Evidence of active infection (e.g.,fever, temperature >38 degrees C and/or WBC >15,000)
  • Pre-planned staged procedure of target aneurysm
  • mRS score 3 or more
  • Hunt Hess Score more than 3 for subjects with ruptured aneurysm

Where in United States

  • Cleveland ClinicCleveland, United States
  • McLaren Health CareGrand Blanc, United States
  • Northwell Health- Lenox Hill HospitalNew York, United States
  • SSM Health St. Anthony's HospitalOklahoma City, United States

About the trial

What the trial wants to find out

Prospective, multi-center, non-randomized registry / study, up to 164 patients enrolled and followed at 180 days +/- 45 days and again at 365 days +/- 90 days post procedure

The group in the trial

  • Interventional treatmentOther group

    Open label

    Treatment: i-ED COIL

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
7 October 2025